<p>CHO cells transduced with the empty vector (Mock) or with WT, R749W or E757K hEcadherin were treated with 2% DMSO or with Medium, and the interaction of E-cadherin with PIPKIγ (A), p120- (B) and β-catenins (C) was assessed by PLA. Cells were fixed and incubated with antibodies against E-cadherin and PIPKIγ or E-cadherin and p120 or E-cadherin and β-catenin. In the negative control, CHO WT cells were incubated only with the antibody against E-cadherin. Close proximity of oligonucleotide-ligated secondary antibodies allows a rolling-circle amplification and the detection of the rolling-circle amplification product by a fluorescently labelled probe. Nuclei were counterstained with DAPI. The pictures were taken under a 40× objective. The num...
<p>DPCs were allowed to attach overnight and then treated (60 min) with cycloheximide (10 μg/ml) and...
<p>HepG2 cells were seeded onto glass coverslips at 3 x104 cells/ml in 24-well plates overnight and ...
<p>(A) NHU cells expressing β-catenin shRNA (NHU-β-cat-KD) and their isogenic controls expressing sc...
<p>CHO cells stably transduced with the empty vector (Mock) or with WT, R749W or E757K hEcadherin we...
<p>HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and total cell lysa...
<p>(A) MEF PS (−/−) cells were transfected with npPS1 or pPS1: pcDNA3.1-<i>Myc/His</i>-PS1 (npPS1) o...
<p>A) Schematic drawing of two contacting cells showing the areas of the cell surface in which α3β4-...
<p>Two different methods were used to assess the effect of LMP1 on this interaction. Firstly, E-cadh...
<p>(A) Schematic representation of E-cadherin and its three derivatives. E-cadherin associates with ...
<p>(A) NHU cells expressing the H-2K<sup>d</sup>-E-cad mutant (NHU-ECmut) and their isogenic control...
<p>(A) E-cadherin was immunoprecipitated from control and ScrbKD lysates as described in Methods, an...
<p>(<b>A</b>) Control cells were treated with 4 mM EGTA for 2 h to disrupt cell-cell contacts, fixed...
<p>(A) Dox-repressible expression of DNCT in MDCK cells. An MDCK derivative (T23), expressing the te...
<p>(A) Immunofluorescence staining of B6 ES cells for E-cadherin and cell nuclei in the presence of ...
<p><b>A</b>, HT29 cells were left intact or incubated for 1 h at 37°C with FRA3 (500 ng/ml), FRA3-E3...
<p>DPCs were allowed to attach overnight and then treated (60 min) with cycloheximide (10 μg/ml) and...
<p>HepG2 cells were seeded onto glass coverslips at 3 x104 cells/ml in 24-well plates overnight and ...
<p>(A) NHU cells expressing β-catenin shRNA (NHU-β-cat-KD) and their isogenic controls expressing sc...
<p>CHO cells stably transduced with the empty vector (Mock) or with WT, R749W or E757K hEcadherin we...
<p>HUVEC were treated with PAI-039 (25 μM) or solvent (DMSO 0.1%) for four hours and total cell lysa...
<p>(A) MEF PS (−/−) cells were transfected with npPS1 or pPS1: pcDNA3.1-<i>Myc/His</i>-PS1 (npPS1) o...
<p>A) Schematic drawing of two contacting cells showing the areas of the cell surface in which α3β4-...
<p>Two different methods were used to assess the effect of LMP1 on this interaction. Firstly, E-cadh...
<p>(A) Schematic representation of E-cadherin and its three derivatives. E-cadherin associates with ...
<p>(A) NHU cells expressing the H-2K<sup>d</sup>-E-cad mutant (NHU-ECmut) and their isogenic control...
<p>(A) E-cadherin was immunoprecipitated from control and ScrbKD lysates as described in Methods, an...
<p>(<b>A</b>) Control cells were treated with 4 mM EGTA for 2 h to disrupt cell-cell contacts, fixed...
<p>(A) Dox-repressible expression of DNCT in MDCK cells. An MDCK derivative (T23), expressing the te...
<p>(A) Immunofluorescence staining of B6 ES cells for E-cadherin and cell nuclei in the presence of ...
<p><b>A</b>, HT29 cells were left intact or incubated for 1 h at 37°C with FRA3 (500 ng/ml), FRA3-E3...
<p>DPCs were allowed to attach overnight and then treated (60 min) with cycloheximide (10 μg/ml) and...
<p>HepG2 cells were seeded onto glass coverslips at 3 x104 cells/ml in 24-well plates overnight and ...
<p>(A) NHU cells expressing β-catenin shRNA (NHU-β-cat-KD) and their isogenic controls expressing sc...